Episode Details
Back to EpisodesAUNA Stock: AVOID Call - 73 Pct EPS Miss And FY26 Guide Cut Q1 2026
Published 1 month, 1 week ago
Description
Auna SA Q1 2026 earnings breakdown - conversational walkthrough with a price-aware verdict and Wall Street consensus comparison.
THE CALL: AVOID (4/5 conviction, STRONG)
- CURRENT @ $4.38 - AVOID
- BUY below $3.00 with $2.00 stop
- AVOID above $5.50
TRIGGER: Two consecutive quarters of operating margin above 12 percent AND net-debt-to-EBITDA below 4.5x
WINDOW: Through Q3 FY26 earnings (Nov 2026) - revisit only after margin stabilization signal
TRACKER: charged-alpha.com/calls/AUNA
WALL STREET CONSENSUS
- Ratings: 0 Strong Buy / 1 Buy / 3 Hold / 1 Sell / 0 Strong Sell - HOLD
- Median 12-month price target: $6.50 (range $4 - $9)
- Charged Alpha vs consensus: MORE NEGATIVE
THESIS
Auna is a LATAM hospital ADR with currency exposure and 5x net-debt leverage that just had a 73 percent EPS miss.
Bull lever: Mexican peso stabilization combined with Auntras integration synergy capture could restore 12 percent op margin by FY27.
Key risk: Mexican peso continues depreciating against the Sol or EBITDA cover drops below 2x triggering a refinancing event.
QUALITY CHECK
- Management quality grade: C+ (Jesus Zamora has executed the regional roll-up but the FY26 EPS guidance cut after just one quarter signals visibility issues at the segment level.)
- Earnings quality grade: C (GAAP and adjusted EPS aligned at 5 cents. FX-translation losses are real but recurring. Cash conversion held up at 142 percent of net income.)
CHAPTERS
0:00 Hook
0:39 The Print
1:33 The Trend
2:14 The Segments
3:01 The FCF Bridge
3:48 Guidance & The Narrative Diff
4:59 Peer Dot-Plot
5:30 Management & Earnings Quality
6:52 S8_Call
KEY METRICS - Q1 2026
- Revenue: $336M (+19.0 pct YoY USD, +4.7 pct vs est)
- GAAP EPS: $0.05 (vs $0.19 est, -73.7 pct miss)
- EPS YoY: -73.7 pct
- Gross margin: 36.5 pct (down 150bps YoY)
- Operating margin: 7.0 pct GAAP (down 700bps YoY)
- Net income: $12M
- Free cash flow: $17M (5.1 pct margin)
- Net debt: $3.32B | Net-debt-to-EBITDA: 5.4x (peer median 2.5x)
SEGMENT BREAKDOWN
- Peru Hospitals + Oncosalud (45 pct): +11 pct YoY -- cash engine
- Mexico Hospitals (38 pct): +28 pct YoY on Auntras acquisition; FX headwind
- Colombia Hospitals (17 pct): +22 pct YoY
- Operating margin compression concentrated in Mexico: peso -9 pct vs Sol
GUIDANCE - CUT on EPS line
- FY26 sales growth: 12 pct to 18 pct (vs Street 14)
- FY26 EPS growth: CUT to -30 pct to -10 pct (vs Street +5 pct)
- Q2 revenue $340-$360M, midpoint in-line with consensus
NARRATIVE DIFF - what changed in management tone
- Q4 FY25 call (Mar): "continued margin recovery into second half of 2026"
- Q1 FY26 call (May): "reducing FY26 EPS outlook on Mexican peso depreciation and integration costs"
- Tone shift: constructive - defensive
DATA SOURCES
- FMP (financialmodelingprep.com)
- Auna SA Q1 2026 Press Release (2026-05-19)
- Q1 2026 Earnings Call commentary
DISCLAIMER
This is for informational and entertainment purposes only. Not financial advice. Charged Alpha does not have a position in AUNA. Do your own research before any investment decision.
#AUNA #Auna #LATAMHealthcare #HospitalADR #earnings #investing #ChargedAlpha